While the overall rate of pediatric admissions for dermatologic conditions has declined from 2012 to 2022, significant disparities remain.

Tildrakizumab, risankizumab, and guselkumab are effective for psoriasis in high-impact areas, though effectiveness varies across affected sites.

The EPA announced plans to add microplastics and leftover medications to its list of priority pollutants in drinking water.

The table below is a review of notable updates that occurred in March 2026 for investigational products in development (not an inclusive list). Click on the status to view our full coverage.

Patients with jDM vs aDM show distinct organ patterns, autoantibody profiles, treatment courses, and outcomes.

The American Heart Association recommended eating plant-based proteins and avoiding dairy fat, contradicting recent federal dietary guidance.

Former US Surgeon General Dr Jerome Adams has joined others in criticizing President Donald Trump’s nominee for the role, Dr Casey Means.

The US Centers for Disease Control temporarily paused more than 24 types of laboratory tests, reportedly because of a routine review.

Intermittent tacrolimus after dupilumab discontinuation in patients with AD was associated with longer time to disease flare than on-demand therapy.

Phase 3 studies showed zasocitinib, a highly selective oral tyrosine kinase 2 inhibitor, provided rapid, durable skin improvement.

Adult acne is affected by sedentary behavior, exercise, and sleep, with depression and anxiety having a significant effect on this relationship.

Tralokinumab is effective and safe for the treatment of patients with moderate to severe AD through 6 total years of treatment.